CytomX Therapeutics Statistics
NASDAQ: CTMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.55-0.01 (-0.39%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CytomX Therapeutics by the numbers
CytomX Therapeutics has a market capitalization of $555.6 million based on 217.90M shares outstanding. With trailing EPS of $-0.51, CytomX Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.7% below its 50-day average and 36.9% below its 200-day average.
Average daily trading volume is 3.36M shares, or about $8.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTMX valuation vs. peer median
| Metric | CTMX | Peer median | Difference |
|---|---|---|---|
| Market cap | $555.64M | $564.89M | -2% |
| Avg. volume | 3.36M | 664.08K | +406% |
Peer median across 8 companies: MNPR, PHAT, CRMD, STTK, EVO, AQST, BLSM, OCS.
Valuation
- Market cap
- $555.64M
- EPS (TTM)
- $-0.51
- Shares outstanding
- 217.90M
Price and trading
- Previous close
- 2.56
- Open
- 2.53
- Day range
- 2.52 – 2.65
- 52-week range
- 2.48 – 8.21
- 52-week change
- -23.42%
- Beta
- —
- Volume
- 2.34M
- Average volume
- 3.36M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 555.64M
- Forward Pe
- -5.39
- Eps
- -0.51
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.21
- Week52 Low
- 2.48
- Avg Volume
- 3.36M
- Shares Outstanding
- 217.90M
- Ma50
- 3.17
- Ma200
- 4.04
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -68.94%
- Pct From52w Low
- 2.82%